AG˹ٷ

STOCK TITAN

[8-K] New York Community Bancorp, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

On 24 Jul 2025 AEye, Inc. (Nasdaq: LIDR) filed Amendment No. 3 to its 424(b)(5) prospectus supplements for its Form S-3 at-the-market (ATM) equity program with A.G.P./Alliance Global Partners. The amendment raises the maximum aggregate offering price that may be sold under the Sales Agreement from $2.6 million to $23.728 million, equal to one-third of the company’s $71.2 million public float, as permitted by General Instruction I.B.6.

AEye has already issued $14.993 million of securities under this rule in the last 12-month period; combined future sales cannot surpass the updated $23.728 million cap unless a further supplement is filed. Key metrics disclosed: 25.42 million shares outstanding, of which 24.38 million are held by non-affiliates; last reported share price $2.92. The company continues to qualify as an “emerging growth� and “smaller reporting� company, benefiting from reduced reporting requirements. Investors are directed to previously disclosed risk factors for additional considerations.

Il 24 luglio 2025, AEye, Inc. (Nasdaq: LIDR) ha presentato la Terza Modifica ai supplementi del prospetto 424(b)(5) relativi al suo programma azionario at-the-market (ATM) tramite il modulo S-3 con A.G.P./Alliance Global Partners. La modifica aumenta il prezzo massimo aggregato dell'offerta che può essere venduto ai sensi dell'Accordo di Vendita da 2,6 milioni di dollari a 23,728 milioni di dollari, pari a un terzo del flottante pubblico della società di 71,2 milioni di dollari, come consentito dall'Istruzione Generale I.B.6.

AEye ha già emesso titoli per un valore di 14,993 milioni di dollari nell'ultimo periodo di 12 mesi secondo questa normativa; le vendite future combinate non possono superare il nuovo limite di 23,728 milioni di dollari a meno che non venga presentato un ulteriore supplemento. Metriche chiave comunicate: 25,42 milioni di azioni in circolazione, di cui 24,38 milioni detenute da non affiliati; ultimo prezzo di chiusura riportato 2,92 dollari. La società continua a qualificarsi come "emerging growth" e "smaller reporting" company, beneficiando di requisiti di rendicontazione ridotti. Si invita gli investitori a consultare i fattori di rischio già divulgati per ulteriori dettagli.

El 24 de julio de 2025, AEye, Inc. (Nasdaq: LIDR) presentó la Enmienda Nº 3 a sus suplementos del prospecto 424(b)(5) para su programa de acciones at-the-market (ATM) bajo el Formulario S-3 con A.G.P./Alliance Global Partners. La enmienda eleva el precio máximo agregado de la oferta que puede venderse bajo el Acuerdo de Venta de 2,6 millones de dólares a 23,728 millones de dólares, equivalente a un tercio del flotante público de la compañía de 71,2 millones de dólares, según lo permitido por la Instrucción General I.B.6.

AEye ya ha emitido valores por un total de 14,993 millones de dólares bajo esta regla en los últimos 12 meses; las ventas futuras combinadas no pueden superar el límite actualizado de 23,728 millones de dólares a menos que se presente un suplemento adicional. Métricas clave divulgadas: 25,42 millones de acciones en circulación, de las cuales 24,38 millones están en manos de no afiliados; último precio reportado por acción 2,92 dólares. La compañía sigue calificando como una empresa de “crecimiento emergente� y de “menor reporte�, beneficiándose de requisitos de reporte reducidos. Se recomienda a los inversores revisar los factores de riesgo previamente divulgados para consideraciones adicionales.

2025� 7� 24�, AEye, Inc. (나스�: LIDR)� A.G.P./Alliance Global Partners와 함께 Form S-3� 424(b)(5) 설명� 보충서에 대� � 번째 수정안을 제출했습니다. � 수정안은 판매 계약� 따른 최대 � 공모 가�260� 달러에서 2,372� 8� 달러� 상향 조정했으�, 이는 회사� 7,120� 달러 공중 유통 주식� 3분의 1� 해당하며 일반 지� I.B.6� 따라 허용됩니�.

AEye� 지� 12개월 동안 � 규정� 따라 이미 1,499� 3� 달러 상당� 증권� 발행했으�, 향후 판매액은 추가 보충서가 제출되지 않는 � 업데이트� 2,372� 8� 달러 한도� 초과� � 없습니다. 주요 지표는 다음� 같습니다: 2,542� � 발행 주식 � 2,438� 주는 비계열사 보유; 마지� 보고� 주가 2.92달러. 회사� 계속해서 "신흥 성장" � "소규� 보고" 기업으로 분류되어 보고 요건� 완화� 혜택� 받고 있습니다. 투자자들은 추가 고려 사항� 위해 이전� 공개� 위험 요소� 참고하시� 바랍니다.

Le 24 juillet 2025, AEye, Inc. (Nasdaq : LIDR) a déposé l’Amendement n° 3 à ses suppléments de prospectus 424(b)(5) pour son programme d’actions en vente au marché (ATM) selon le formulaire S-3 auprès de A.G.P./Alliance Global Partners. L’amendement augmente le prix d’offre maximal agrégé pouvant être vendu dans le cadre de l’Accord de Vente, passant de 2,6 millions de dollars à 23,728 millions de dollars, soit un tiers du flottant public de la société de 71,2 millions de dollars, conformément à la Directive Générale I.B.6.

AEye a déjà émis des titres pour une valeur de 14,993 millions de dollars au cours des 12 derniers mois selon cette règle ; les ventes futures combinées ne peuvent dépasser le plafond actualisé de 23,728 millions de dollars sauf dépôt d’un supplément supplémentaire. Principaux indicateurs divulgués : 25,42 millions d’actions en circulation, dont 24,38 millions détenues par des non-affiliés ; dernier cours rapporté 2,92 dollars. La société continue de se qualifier comme une entreprise « en croissance émergente » et « à plus petite échelle », bénéficiant d’exigences de reporting réduites. Les investisseurs sont invités à consulter les facteurs de risque précédemment divulgués pour plus de précisions.

Am 24. Juli 2025 reichte AEye, Inc. (Nasdaq: LIDR) die dritte Änderung zu seinen 424(b)(5) Prospektergänzungen für das at-the-market (ATM) Aktienprogramm im Formular S-3 bei A.G.P./Alliance Global Partners ein. Die Änderung erhöht den maximalen Gesamtangebotspreis, der gemäß dem Verkaufsvertrag verkauft werden darf, von 2,6 Millionen US-Dollar auf 23,728 Millionen US-Dollar, was einem Drittel des öffentlichen Streubesitzes des Unternehmens von 71,2 Millionen US-Dollar entspricht, wie durch Allgemeine Anweisung I.B.6 erlaubt.

AEye hat in den letzten 12 Monaten bereits Wertpapiere im Wert von 14,993 Millionen US-Dollar unter dieser Regelung ausgegeben; zukünftige kombinierte Verkäufe dürfen die aktualisierte Obergrenze von 23,728 Millionen US-Dollar nicht überschreiten, es sei denn, es wird ein weiterer Nachtrag eingereicht. Wichtige Kennzahlen: 25,42 Millionen ausstehende Aktien, davon 24,38 Millionen im Besitz von Nichtverbundenen; letzter gemeldeter Aktienkurs 2,92 US-Dollar. Das Unternehmen qualifiziert sich weiterhin als „emerging growth� und „smaller reporting� Unternehmen und profitiert von reduzierten Berichtspflichten. Investoren werden auf zuvor veröffentlichte Risikofaktoren für weitere Hinweise verwiesen.

Positive
  • Increased capital flexibility: authority to sell up to $23.728 M of common stock provides a readily accessible funding source.
  • Regulatory compliance affirmed: filing demonstrates adherence to Form S-3 I.B.6 limits and ongoing Nasdaq listing.
Negative
  • Dilution risk: issuance of additional stock—up to one-third of public float—could dilute existing shareholders.
  • Significant prior sales: $14.993 M already sold in last 12 months means only about $8.7 M capacity remains before a new supplement is needed.

Insights

TL;DR: Amendment ups ATM capacity to $23.7 M, improving liquidity but adding dilution risk; overall impact is neutral.

The filing expands AEye’s at-the-market shelf capacity to one-third of public float, giving management flexibility to raise up to $8.7 M more before reaching the 12-month cap (after $15 M already sold). Additional cash could support operations without a traditional follow-on offering, but incremental issuance at roughly $3/share may materially dilute existing holders. No use-of-proceeds update or financial guidance is provided, limiting visibility on capital needs. Because the amendment simply adjusts the ceiling within regulatory limits and does not mandate immediate issuance, I view the disclosure as neutral for valuation in the near term.

Il 24 luglio 2025, AEye, Inc. (Nasdaq: LIDR) ha presentato la Terza Modifica ai supplementi del prospetto 424(b)(5) relativi al suo programma azionario at-the-market (ATM) tramite il modulo S-3 con A.G.P./Alliance Global Partners. La modifica aumenta il prezzo massimo aggregato dell'offerta che può essere venduto ai sensi dell'Accordo di Vendita da 2,6 milioni di dollari a 23,728 milioni di dollari, pari a un terzo del flottante pubblico della società di 71,2 milioni di dollari, come consentito dall'Istruzione Generale I.B.6.

AEye ha già emesso titoli per un valore di 14,993 milioni di dollari nell'ultimo periodo di 12 mesi secondo questa normativa; le vendite future combinate non possono superare il nuovo limite di 23,728 milioni di dollari a meno che non venga presentato un ulteriore supplemento. Metriche chiave comunicate: 25,42 milioni di azioni in circolazione, di cui 24,38 milioni detenute da non affiliati; ultimo prezzo di chiusura riportato 2,92 dollari. La società continua a qualificarsi come "emerging growth" e "smaller reporting" company, beneficiando di requisiti di rendicontazione ridotti. Si invita gli investitori a consultare i fattori di rischio già divulgati per ulteriori dettagli.

El 24 de julio de 2025, AEye, Inc. (Nasdaq: LIDR) presentó la Enmienda Nº 3 a sus suplementos del prospecto 424(b)(5) para su programa de acciones at-the-market (ATM) bajo el Formulario S-3 con A.G.P./Alliance Global Partners. La enmienda eleva el precio máximo agregado de la oferta que puede venderse bajo el Acuerdo de Venta de 2,6 millones de dólares a 23,728 millones de dólares, equivalente a un tercio del flotante público de la compañía de 71,2 millones de dólares, según lo permitido por la Instrucción General I.B.6.

AEye ya ha emitido valores por un total de 14,993 millones de dólares bajo esta regla en los últimos 12 meses; las ventas futuras combinadas no pueden superar el límite actualizado de 23,728 millones de dólares a menos que se presente un suplemento adicional. Métricas clave divulgadas: 25,42 millones de acciones en circulación, de las cuales 24,38 millones están en manos de no afiliados; último precio reportado por acción 2,92 dólares. La compañía sigue calificando como una empresa de “crecimiento emergente� y de “menor reporte�, beneficiándose de requisitos de reporte reducidos. Se recomienda a los inversores revisar los factores de riesgo previamente divulgados para consideraciones adicionales.

2025� 7� 24�, AEye, Inc. (나스�: LIDR)� A.G.P./Alliance Global Partners와 함께 Form S-3� 424(b)(5) 설명� 보충서에 대� � 번째 수정안을 제출했습니다. � 수정안은 판매 계약� 따른 최대 � 공모 가�260� 달러에서 2,372� 8� 달러� 상향 조정했으�, 이는 회사� 7,120� 달러 공중 유통 주식� 3분의 1� 해당하며 일반 지� I.B.6� 따라 허용됩니�.

AEye� 지� 12개월 동안 � 규정� 따라 이미 1,499� 3� 달러 상당� 증권� 발행했으�, 향후 판매액은 추가 보충서가 제출되지 않는 � 업데이트� 2,372� 8� 달러 한도� 초과� � 없습니다. 주요 지표는 다음� 같습니다: 2,542� � 발행 주식 � 2,438� 주는 비계열사 보유; 마지� 보고� 주가 2.92달러. 회사� 계속해서 "신흥 성장" � "소규� 보고" 기업으로 분류되어 보고 요건� 완화� 혜택� 받고 있습니다. 투자자들은 추가 고려 사항� 위해 이전� 공개� 위험 요소� 참고하시� 바랍니다.

Le 24 juillet 2025, AEye, Inc. (Nasdaq : LIDR) a déposé l’Amendement n° 3 à ses suppléments de prospectus 424(b)(5) pour son programme d’actions en vente au marché (ATM) selon le formulaire S-3 auprès de A.G.P./Alliance Global Partners. L’amendement augmente le prix d’offre maximal agrégé pouvant être vendu dans le cadre de l’Accord de Vente, passant de 2,6 millions de dollars à 23,728 millions de dollars, soit un tiers du flottant public de la société de 71,2 millions de dollars, conformément à la Directive Générale I.B.6.

AEye a déjà émis des titres pour une valeur de 14,993 millions de dollars au cours des 12 derniers mois selon cette règle ; les ventes futures combinées ne peuvent dépasser le plafond actualisé de 23,728 millions de dollars sauf dépôt d’un supplément supplémentaire. Principaux indicateurs divulgués : 25,42 millions d’actions en circulation, dont 24,38 millions détenues par des non-affiliés ; dernier cours rapporté 2,92 dollars. La société continue de se qualifier comme une entreprise « en croissance émergente » et « à plus petite échelle », bénéficiant d’exigences de reporting réduites. Les investisseurs sont invités à consulter les facteurs de risque précédemment divulgués pour plus de précisions.

Am 24. Juli 2025 reichte AEye, Inc. (Nasdaq: LIDR) die dritte Änderung zu seinen 424(b)(5) Prospektergänzungen für das at-the-market (ATM) Aktienprogramm im Formular S-3 bei A.G.P./Alliance Global Partners ein. Die Änderung erhöht den maximalen Gesamtangebotspreis, der gemäß dem Verkaufsvertrag verkauft werden darf, von 2,6 Millionen US-Dollar auf 23,728 Millionen US-Dollar, was einem Drittel des öffentlichen Streubesitzes des Unternehmens von 71,2 Millionen US-Dollar entspricht, wie durch Allgemeine Anweisung I.B.6 erlaubt.

AEye hat in den letzten 12 Monaten bereits Wertpapiere im Wert von 14,993 Millionen US-Dollar unter dieser Regelung ausgegeben; zukünftige kombinierte Verkäufe dürfen die aktualisierte Obergrenze von 23,728 Millionen US-Dollar nicht überschreiten, es sei denn, es wird ein weiterer Nachtrag eingereicht. Wichtige Kennzahlen: 25,42 Millionen ausstehende Aktien, davon 24,38 Millionen im Besitz von Nichtverbundenen; letzter gemeldeter Aktienkurs 2,92 US-Dollar. Das Unternehmen qualifiziert sich weiterhin als „emerging growth� und „smaller reporting� Unternehmen und profitiert von reduzierten Berichtspflichten. Investoren werden auf zuvor veröffentlichte Risikofaktoren für weitere Hinweise verwiesen.

false000091007300009100732025-07-252025-07-250000910073us-gaap:CommonStockMember2025-07-252025-07-250000910073nycb:BifurcatedOptionNotesUnitSecuritiesMember2025-07-252025-07-250000910073nycb:FixedToFloatingRateSeriesANoncumulativePerpetualPreferredStockMember2025-07-252025-07-25

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 25, 2025
 
 
FLAGSTAR FINANCIAL, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 1-31565 06-1377322
(State or Other Jurisdiction
of Incorporation)
 Commission File Number (IRS Employer Identification No.)
102 Duffy Avenue,Hicksville,New York11801
(Address of principal executive offices)
(516) 683-4100
(Registrant's telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each classTrading symbol(s)Name of each exchange on which registered
Common stock, $0.01 par value per shareFLGNew York Stock Exchange
Bifurcated Option Note Unit Securities SM FLG PRUNew York Stock Exchange
Depositary Shares each representing a 1/40th interest in a share of Fixed-to-Floating Rate Series A Noncumulative Perpetual Preferred StockFLG PRANew York Stock Exchange
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b-2).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act.




Item 2.02Results of Operations and Financial Condition

On July 25, 2025, Flagstar Financial, Inc. (the “Company”) issued a news release reporting its financial results for the quarter ended June 30, 2025. A copy of the news release is attached as Exhibit 99.1 to this report.

Item 9.01Financial Statements and Exhibits

(d) Attached as Exhibit 99.1 is the news release issued by the Company on July 25, 2025 to report its financial results for the quarter ended June 30, 2025.

ExhibitDescription of Exhibit
No.
99.1  
Press release issued by the Company on July 25, 2025
104  Cover Page Interactive Data File (embedded within the Inline XBRL document).



SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
Date:July 25, 2025 FLAGSTAR FINANCIAL, INC.
/s/ Salvatore DiMartino
Salvatore DiMartino
Executive Vice President and Director of Investor Relations


FAQ

How much stock can AEye (LIDR) now sell under its ATM program?

The amendment allows sales of up to $23.728 million of common stock, equal to one-third of the current public float.

How much has AEye already raised via the ATM in the past 12 months?

AEye disclosed $14.993 million in securities sold during the 12-month period ending 24 Jul 2025.

What is AEye’s current public float and share price?

Public float is $71.186 million based on 24.38 million non-affiliate shares at $2.92 per share.

Will the amendment immediately dilute existing shareholders?

Dilution occurs only if and when the company issues shares; the filing merely increases the capacity to do so.

Why did AEye file Amendment No. 3 to its prospectus supplements?

To update the maximum amount it can sell under Form S-3 General Instruction I.B.6 and reflect current float calculations.
New York Comnity

NYSE:NYCB

NYCB Rankings

NYCB Latest News

NYCB Latest SEC Filings

NYCB Stock Data

4.38B
379.92M
0.44%
69.98%
9.47%
Banks - Regional
Savings Institutions, Not Federally Chartered
United States
HICKSVILLE